Compare Illumina vs Sirion Biotech
Customers evaluate the quality of Illumina's products using the following success metrics.
Overview
Illumina is 25 yrs old and is based in United States.
Illumina works to apply technologies and revolutionary assays to the analysis of genetic variation and function. It offers collaborative interactions, rapid delivery of solutions, and focuses on customers. Illumina's array-based solutions for DNA, RNA, and protein analysis serve as tools for disease research, drug development, and the development of molecular tests in the clinic. The company was founded in 1998 and is based in San Diego, California.
Sirion Biotech is 18 yrs old and is based in Germany.
SIRION Biotech is a viral vector technology company for gene and cell therapy, including vaccine development. The company offers comprehensive viral vector technology platforms based on lentiviruses, adenoviruses, and adeno-associated viruses (AAV) custom engineering, and manufacturing to expedites gene therapy research, cell therapy research, and advance drug development. It is based in Martinsried, Germany. On June 22, 2021, Sirion Biotech was acquired by PerkinElmer. The terms of the transaction were not disclosed.
Demo Video
Leadership
Maneesh Jain (Founder)
Christian Thirion Dr (Founder)
Investors
LRG Capital Group, Comdisco Ventures
PerkinElmer, Bayern Kapital
Product
Benefits
Products
Customers
Known Partners
Why They Buy
Information not available because Illumina has not claimed their profile.
Work for Illumina? Claim your profile by submitting an Analyst Briefing. By submitting you can
Work for Illumina?
Claim your profile now.
Information not available because Sirion Biotech has not claimed their profile.
Work for Sirion Biotech? Claim your profile by submitting an Analyst Briefing. By submitting you can
Work for Sirion Biotech?
Claim your profile now.
News & Analysis
Illumina has been mentioned in our research 4 times.
Sirion Biotech has not been mentioned in our research.
Research Articles
Expert Collections
Unicorns- Billion Dollar Startups
115 items
Synthetic Biology
382 items
Regenerative Medicine
1,818 items
Regenerative medicine refers to the process of activating, replacing, engineering or regenerating human genetic material, cells, tissues or organs to restore normal function. It also includes bioengineered tissues used for in vitro testing (e.g. organ-on-a-chip, organoids).